Artivion Inc
NYSE:AORT

Watchlist Manager
Artivion Inc Logo
Artivion Inc
NYSE:AORT
Watchlist
Price: 26.33 USD -1.13% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
Artivion Inc?
Write Note

Intrinsic Value

The intrinsic value of one AORT stock under the Base Case scenario is 24.25 USD. Compared to the current market price of 26.33 USD, Artivion Inc is Overvalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AORT Intrinsic Value
24.25 USD
Overvaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Artivion Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for AORT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about AORT?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Artivion Inc

Provide an overview of the primary business activities
of Artivion Inc.

What unique competitive advantages
does Artivion Inc hold over its rivals?

What risks and challenges
does Artivion Inc face in the near future?

Has there been any significant insider trading activity
in Artivion Inc recently?

Summarize the latest earnings call
of Artivion Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Artivion Inc.

Provide P/S
for Artivion Inc.

Provide P/E
for Artivion Inc.

Provide P/OCF
for Artivion Inc.

Provide P/FCFE
for Artivion Inc.

Provide P/B
for Artivion Inc.

Provide EV/S
for Artivion Inc.

Provide EV/GP
for Artivion Inc.

Provide EV/EBITDA
for Artivion Inc.

Provide EV/EBIT
for Artivion Inc.

Provide EV/OCF
for Artivion Inc.

Provide EV/FCFF
for Artivion Inc.

Provide EV/IC
for Artivion Inc.

Show me price targets
for Artivion Inc made by professional analysts.

What are the Revenue projections
for Artivion Inc?

How accurate were the past Revenue estimates
for Artivion Inc?

What are the Net Income projections
for Artivion Inc?

How accurate were the past Net Income estimates
for Artivion Inc?

What are the EPS projections
for Artivion Inc?

How accurate were the past EPS estimates
for Artivion Inc?

What are the EBIT projections
for Artivion Inc?

How accurate were the past EBIT estimates
for Artivion Inc?

Compare the revenue forecasts
for Artivion Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Artivion Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Artivion Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Artivion Inc compared to its peers.

Compare the P/E ratios
of Artivion Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Artivion Inc with its peers.

Analyze the financial leverage
of Artivion Inc compared to its main competitors.

Show all profitability ratios
for Artivion Inc.

Provide ROE
for Artivion Inc.

Provide ROA
for Artivion Inc.

Provide ROIC
for Artivion Inc.

Provide ROCE
for Artivion Inc.

Provide Gross Margin
for Artivion Inc.

Provide Operating Margin
for Artivion Inc.

Provide Net Margin
for Artivion Inc.

Provide FCF Margin
for Artivion Inc.

Show all solvency ratios
for Artivion Inc.

Provide D/E Ratio
for Artivion Inc.

Provide D/A Ratio
for Artivion Inc.

Provide Interest Coverage Ratio
for Artivion Inc.

Provide Altman Z-Score Ratio
for Artivion Inc.

Provide Quick Ratio
for Artivion Inc.

Provide Current Ratio
for Artivion Inc.

Provide Cash Ratio
for Artivion Inc.

What is the historical Revenue growth
over the last 5 years for Artivion Inc?

What is the historical Net Income growth
over the last 5 years for Artivion Inc?

What is the current Free Cash Flow
of Artivion Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Artivion Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Artivion Inc

Current Assets 285m
Cash & Short-Term Investments 55m
Receivables 79m
Other Current Assets 151m
Non-Current Assets 504.6m
PP&E 79.1m
Intangibles 408.4m
Other Non-Current Assets 17.1m
Current Liabilities 50.6m
Accounts Payable 11.7m
Accrued Liabilities 35.2m
Other Current Liabilities 3.6m
Non-Current Liabilities 443.9m
Long-Term Debt 316.5m
Other Non-Current Liabilities 127.4m
Efficiency

Earnings Waterfall
Artivion Inc

Revenue
377m USD
Cost of Revenue
-133.3m USD
Gross Profit
243.6m USD
Operating Expenses
-216.4m USD
Operating Income
27.2m USD
Other Expenses
-35.6m USD
Net Income
-8.3m USD

Free Cash Flow Analysis
Artivion Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Artivion experienced a robust second quarter in 2024 with revenues reaching $98 million, representing a 10% increase year-over-year, and a 35% rise in adjusted EBITDA. Leading the growth were On-X valves with a 15% increase, and Stent Grafts at 13%. The company amended its agreements with Endospan, improving acquisition terms and adding funding. Looking ahead, Artivion anticipates annual revenue growth between 10% and 12%, raising its guidance to $388-$396 million. Adjusted EBITDA is expected to grow by 28%-34%, hitting $69-$72 million. Key markets in Latin America and Asia Pacific saw significant expansions, with revenue increases of 25% and 15%, respectively.

What is Earnings Call?
Fundamental Scores

AORT Profitability Score
Profitability Due Diligence

Artivion Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
Positive 3-Years Revenue Growth
34/100
Profitability
Score

Artivion Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

AORT Solvency Score
Solvency Due Diligence

Artivion Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Average Altman Z-Score
51/100
Solvency
Score

Artivion Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AORT Price Targets Summary
Artivion Inc

Wall Street analysts forecast AORT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AORT is 30.93 USD with a low forecast of 29.9 USD and a high forecast of 33.6 USD.

Lowest
Price Target
29.9 USD
14% Upside
Average
Price Target
30.93 USD
17% Upside
Highest
Price Target
33.6 USD
28% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AORT?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AORT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AORT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Artivion Inc Logo
Artivion Inc

Country

United States of America

Industry

Health Care

Market Cap

1.1B USD

Dividend Yield

0%

Description

Artivion, Inc. focuses on developing solutions that address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. The company is headquartered in Kennesaw, Georgia and currently employs 1,300 full-time employees. The firm is focused on developing various solutions that address cardiac and vascular surgeons' challenges in treating patients with aortic diseases. The firm's four groups of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion's cryopreserved cardiac and vascular allograft tissues help in restoring surgeries for adults and pediatric patients. The company offers surgical sealant through BioGlue product. Its surgical aortic valve replacement solutions include On-X Aortic Heart Valves and CryoValve SG Pulmonary Valve Allograft for the Ross procedure. The firm's mitral valve solutions include Chord-X for mitral valve repair and On-X Mitral Heart Valve. Artivion's Cardiac and Vascular Ancillary solutions provide complementary support for the patient's cardiac and vascular surgical procedures.

Contact

GEORGIA
Kennesaw
1655 Roberts Boulevard N W
+17704193355.0
artivion.com

IPO

1993-02-12

Employees

1 300

Officers

See Also

Discover More
What is the Intrinsic Value of one AORT stock?

The intrinsic value of one AORT stock under the Base Case scenario is 24.25 USD.

Is AORT stock undervalued or overvalued?

Compared to the current market price of 26.33 USD, Artivion Inc is Overvalued by 8%.

Back to Top